Markey John 13D and 13G filings for Sonnet BioTherapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-08-07 07:00 am Purchase |
2023-08-07 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 23,295 10.700% |
2,273![]() (+10.81%) |
Filing |
2023-07-17 07:00 am Purchase |
2023-07-17 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 21,023 11.100% |
2,244![]() (+11.95%) |
Filing |
2023-07-07 07:00 am Purchase |
2023-07-07 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 18,778 9.900% |
2,699![]() (+16.78%) |
Filing |
2023-06-30 08:40 am Purchase |
2023-06-30 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 16,080 8.500% |
625![]() (+4.04%) |
Filing |
2023-06-12 10:39 am Purchase |
2023-06-12 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 15,455 9.900% |
2,386![]() (+18.26%) |
Filing |
2023-05-26 10:23 am Purchase |
2023-05-25 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 13,068 8.400% |
2,382![]() (+22.29%) |
Filing |
2023-05-17 3:49 pm Purchase |
2023-05-17 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 10,687 6.850% |
3,184![]() (+42.43%) |
Filing |
2023-05-01 9:49 pm Purchase |
2023-04-28 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 7,503 6.500% |
7,503![]() (New Position) |
Filing |